Sanofi's Dupixent wins U.S. approval for bigger use

Sanofi won expanded U.S. approval for its best-selling Dupixent injection to treat an allergic inflammation of the esophagus, the Food and Drug Administration said on Friday...

Top 3 Technologies Revolutionizing the Drug Discovery Industry

The development of molecular formulations which become drugs for treating diseases is at the center of the pharmaceutical industry

Prochant confirms Key Partnership with VGM & Associates: HME Industry Update

The 2020s changed the home healthcare industry forever. The Home Medical Equipment (HME) segment of that industry is under more strain than ever. The increase in demand coupled with staffing shortages revealed critical faults in the billing process f

Glenmark Pharmaceuticals receives ANDA authorization for prostate cancer tablets

The United States Food and Drug Administration (USFDA) has granted final approval to Glenmark Pharmaceuticals Inc., USA (Glenmark) for Abiraterone Acetate Tablets...

Biocon Biologics and Viatris launched Abevmy the third oncology biosimilar in Canada

Biocon Biologics, a subsidiary of biopharmaceutical major Biocon and Viatris, an American global healthcare company launched Abevmy (bBevacizumab) , the oncology biosimilar in Canada...

Dr Reddy's Lab to approach regulator for Sputnik Light as universal vaccination dose

Dr Reddy's Laboratories is hoping to go to a regulator for its single-dose Sputnik Light jab as booster dose for approvals by June-end or early July, a senior official of the city- based drug-maker said on Thursday. Deepak Sapra, CEO...

Dr Reddy's Labs Q4 outcome: consolidated profit tanks 76% YoY to Rs 88 crore

Dr Reddy's Laboratories on Thursday said its consolidated net profit for the quarter ended March 2022 dropped to 75.85 per cent to Rs 87.5 crore, compared with Rs 362.4 crore in the same quarter last year...

CCI clears Serum Institute Life Sciences-Biocon Biologics deal

The Competition Commission of India (CCI) has approved a proposed deal involving Serum Institute Life Sciences, Covidshield Technologies and Biocon Biologics. Once the deal is complete, Serum Institute Life Sciences Pvt Ltd will have about...

HempStreet partners with Gynica to boost combined R&D for women's health with cannabinoid-based phytomedicine

HempStreet, India's first research to retail venture in the ayurvedic cannabis sector has partnered with Gynica, an R&D company based out of Israel focused on changing the culture of gynaecological treatment through clinically proven...

Goldman Sachs likely to invest Rs 2,700 crore in PharmEasy

Goldman Sachs is in advanced talks to invest about $350 million (Rs 2,700 crore) in API Holdings, the parent of online pharmacy PharmEasy, in a structured debt transaction, people in the know said...

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.